Latest News

Micron's stock is off its all-time high, but not for long.

Biogen (NASDAQ:BIIB) is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley event. The company expects a series of late-stage clinical readouts to begin as soon as next quart

Citadel, Ken Griffin's hedge fund, materially increased its stake in AbbVie; here's why you may want to follow that lead.

AI fears are mounting.

XAUUSD: SELL 4306.11-4360.01, TP1-4252.21, TP2-4086.71.A month without swaps on majors! Learn moreLong-term trend: long. The maximum accumulation of volume

There are now over a dozen publicly traded companies with market caps exceeding $1 trillion.

Generating sizable dividends from stocks can help achieve passive income goals or supplement income in retirement.

Viking Therapeutics (NASDAQ:VKTX) said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13 weeks at the highest tested dose. Speaking at the Morgan Stanley Global Healthcare Conference, Pr

Homebuilder Lennar (NYSE:LEN) will be reporting results this Wednesday after market hours. Here’s what you need to know. Lennar missed analysts’ revenue expe...

Record revenue and margin gains as company diversifies into aerospace and edge data centers.

International divestiture deal and $16M cost savings reshape portfolio strategy.

8:45 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-md-remain

8:40 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oii-trigg

8:50 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-eix-the-1

Motley Fool recommends that investors own 50 stocks for diversification, with results to back that up.

8:55 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch Listhttp://buyingbreakouts.com/mon-9-14-ndsn-a-brea

Revolutionize your spine care with the cutting-edge Robotic Endoscopic Spine Surgery, expertly performed by the acclaimed Spine Surgeon, Dr. Andrew Chung.

8:54 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oke-volat

Walking into a Brazilian Jiu-Jitsu academy for the first time can feel exciting and slightly intimidating. You may be wondering whether you are fit enough,

It's not too late to catch up if you're behind your peers. Just don't tarry if you are.

Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference. Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth

The 4% rule is a helpful estimate, but a three-layer income plan shows exactly where your next retirement payment comes from.

The best investments are sometimes the simplest.

Bird Construction stock has delivered impressive gains. Here’s how its growing project pipeline could support the next phase of infrastructure growth.

The 2026 TSX30 list features five Canadian technology companies whose average return reached an extraordinary 981%.